"Bahrain Pharmaceuticals & Healthcare Report Q2 2013" Published
We continue to view Bahrain as one of the more attractive in the Middle East and Africa (MEA) region, mostly on account of the relatively high per capita spending, developed healthcare infrastructure and a solid regulatory background. On the down side, the market's potential will continue to be severely limited by the small population size, which is projected to reach only 1.54mn by 2022. Nevertheless, Bahrain's wealth and private insurance for expatriates will continue to provide opportunities for the placement...
View full press release